Cargando…
Neurofibromatosis type 2 (NF2): A clinical and molecular review
Neurofibromatosis type 2 (NF2) is a tumour-prone disorder characterised by the development of multiple schwannomas and meningiomas. Prevalence (initially estimated at 1: 200,000) is around 1 in 60,000. Affected individuals inevitably develop schwannomas, typically affecting both vestibular nerves an...
Autor principal: | Evans, D Gareth R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708144/ https://www.ncbi.nlm.nih.gov/pubmed/19545378 http://dx.doi.org/10.1186/1750-1172-4-16 |
Ejemplares similares
-
Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma?
por: Evans, D. Gareth R., et al.
Publicado: (2022) -
Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis
por: Bachir, Suha, et al.
Publicado: (2021) -
Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies
por: Ruggieri, M., et al.
Publicado: (2016) -
NF2/Merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations
por: Schroeder, Rebecca Dunbar, et al.
Publicado: (2013) -
Increased risk of breast cancer in neurofibromatosis type 1: current insights
por: Howell, Sacha J, et al.
Publicado: (2017)